Screening and discrimination of optimal prognostic genes for pancreatic cancer based on a prognostic prediction model
Open Access
- 20 August 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in G3 Genes|Genomes|Genetics
- Vol. 11 (11)
- https://doi.org/10.1093/g3journal/jkab296
Abstract
The prognosis of pancreatic cancer is poor because patients are usually asymptomatic in the early stage and the early diagnostic rate is low. Therefore, in this study, we aimed to identify potential prognosis-related genes in pancreatic cancer to improve diagnosis and the outcome of patients. The mRNA expression profile data from The Cancer Genome Atlas database and GSE79668, GSE62452, and GSE28735 datasets from Gene Expression Omnibus were downloaded. The prognosis-relevant genes and clinical factors were analyzed using Cox regression analysis and the optimal gene sets were screened using the Cox proportional model. Next, the Kaplan-Meier survival analysis was used to evaluate the relationship between risk grouping and patient prognosis. Finally, an optimal gene-based prognosis prediction model was constructed and validated using a test dataset to discriminate the model accuracy and reliability. The results showed that 325 expression variable genes were identified, and 48 prognosis-relevant genes and three clinical factors, including lymph node stage (pathologic N), new tumor, and targeted molecular therapy were preliminarily obtained. In addition, a gene set containing 16 optimal genes was identified and included FABP6, MAL, KIF19, and REG4, which were significantly associated with the prognosis of pancreatic cancer. Moreover, a prognosis prediction model was constructed and validated to be relatively accurate and reliable. In conclusion, a gene set consisting of 16 prognosis-related genes was identified and a prognosis prediction model was constructed, which is expected to be applicable in the clinical diagnosis and treatment guidance of pancreatic cancer in the future.Keywords
Funding Information
- National Natural Science Foundation of China (81972280, 81972290)
- “Rising Stars of Medical Talent” Youth Development Program (yyxx201901)
- Outstanding Clinical Discipline Project of Shanghai Pudong (PWYgy2018-02)
This publication has 51 references indexed in Scilit:
- DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal AdenocarcinomaPLOS ONE, 2012
- Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinomaMolecular Cancer, 2010
- The role of kinesin family proteins in tumorigenesis and progressionCancer, 2010
- A preliminary result of three-dimensional microarray technology to gene analysis with endoscopic ultrasound-guided fine-needle aspiration specimens and pancreatic juicesJournal of Experimental & Clinical Cancer Research, 2010
- L1 Penalized Estimation in the Cox Proportional Hazards ModelBiometrical Journal, 2010
- Kinesin-14 Family Proteins HSET/XCTK2 Control Spindle Length by Cross-Linking and Sliding MicrotubulesMolecular Biology of the Cell, 2009
- Inactivation of the MAL Gene in Breast Cancer Is a Common Event That Predicts Benefit from Adjuvant ChemotherapyMolecular Cancer Research, 2009
- MAL promoter hypermethylation as a novel prognostic marker in gastric cancerBritish Journal of Cancer, 2008
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- Confidence intervals for the coefficient of variation for the normal and log normal distributionsBiometrika, 1964